Dual blockade of both PD-1 and CTLA-4 in combination with tumor vaccine has also been shown to enhance tumor rejection in other mouse tumor models such as CT26 colon carcinoma and ID8-VEGF ovarian carcinoma [58]. Here, CTLA4 is linked to neoplasm.